AI-powered stock screener and backtesting platform for US equity traders
Stage
Not given
Not given
Founded
Not given
Not given
Based in
Not given
Not given
Pricing model
Freemium
Freemium
Pricing
Free: €0 with basic learning, company scores, and one watchlist. Research: €9.99 EUR/month for company research, discovery, and five-score breakdowns. Premium: €14.99 EUR/month for broker connections, portfolio tracking, and automated trading.
Not given
Key features
Plain-English lessons and quizzes on investing fundamentals
Five core scores simplifying 88+ metrics for company analysis
Investment discovery with ready-made portfolios and themes
Portfolio tracking and performance monitoring
Broker account integration and connections
Automated portfolio rebalancing with customizable rules
Smart alerts for price changes and company news
Scenario planning and forward-looking forecasts
Market insights tracking news and investor activity
50+ automated trading strategies
Stock screener with technical and fundamental filters
Screener backtesting with historical win rates and drawdowns
Watchlists for tracking stocks
Real-time market news with sentiment analysis
Sector heatmap showing rotation and performance
Economic and corporate event calendar
Seasonality patterns with historical frequency analysis
Chart pattern recognition
AI-powered Dr. Market assistant with real data feeds
What makes it different
Simplifies complex financial information for beginners without requiring prior knowledge
Combines learning, research, portfolio tracking, and automation in a single integrated platform
Works alongside existing brokers rather than replacing them
Provides clear, repeatable process for understanding investments before deciding
Reduces research time by centralizing multiple sources of investment information
AI analysis based only on real market data feeds, never generating numbers from memory
All-in-one trading ecosystem consolidating screening, news, charts, and analysis
Backtesting with complete drawdown visibility alongside win rates
Direct founder support without ticket maze
Analysis tool for validating theses, not investment advice service